Hubbry Logo
Cori cycleCori cycleMain
Open search
Cori cycle
Community hub
Cori cycle
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Cori cycle
Cori cycle
Cori cycle
View on Wikipedia
from Wikipedia
Cori cycle

The Cori cycle (also known as the lactic acid cycle), named after its discoverers, Carl Ferdinand Cori and Gerty Cori,[1] is a metabolic pathway in which lactate, produced by anaerobic glycolysis in muscles, is transported to the liver and converted to glucose, which then returns to the muscles and is cyclically metabolized back to lactate.[2]

Process

[edit]
Carl Cori and Gerty Cori jointly won the 1947 Nobel Prize in Physiology or Medicine, for their discovery of the course of the catalytic conversion of glycogen, of which the Cori cycle is a part.

Muscular activity requires ATP, which is provided by the breakdown of glycogen in the skeletal muscles. The breakdown of glycogen, known as glycogenolysis, releases glucose in the form of glucose 1-phosphate (G1P). The G1P is converted to G6P by phosphoglucomutase. G6P is readily fed into glycolysis, (or can go into the pentose phosphate pathway if G6P concentration is high) a process that provides ATP to the muscle cells as an energy source. During muscular activity, the store of ATP needs to be constantly replenished. When the supply of oxygen is sufficient, this energy comes from feeding pyruvate, one product of glycolysis, into the citric acid cycle, which ultimately generates ATP through oxygen-dependent oxidative phosphorylation.

When oxygen supply is insufficient, typically during intense muscular activity, energy must be released through anaerobic metabolism. Lactic acid fermentation converts pyruvate to lactate by lactate dehydrogenase. Most importantly, fermentation regenerates NAD+, maintaining its concentration so additional glycolysis reactions can occur. The fermentation step oxidizes the NADH produced by glycolysis back to NAD+, transferring two electrons from NADH to reduce pyruvate into lactate. (Refer to the main articles on glycolysis and fermentation for the details.)

Instead of accumulating inside the muscle cells, lactate produced by anaerobic fermentation is taken up by the liver. This initiates the other half of the Cori cycle. In the liver, gluconeogenesis occurs. From an intuitive perspective, gluconeogenesis reverses both glycolysis and fermentation by converting lactate first into pyruvate, and finally back to glucose. The glucose is then supplied to the muscles through the bloodstream; it is ready to be fed into further glycolysis reactions. If muscle activity has stopped, the glucose is used to replenish the supplies of glycogen through glycogenesis.[3]

Overall, the glycolysis steps of the cycle produce 2 ATP molecules at a cost of 6 ATP molecules consumed in the gluconeogenesis steps. Each iteration of the cycle must be maintained by a net consumption of 4 ATP molecules. As a result, the cycle cannot be sustained indefinitely. The intensive consumption of ATP molecules in the Cori cycle shifts the metabolic burden from the muscles to the liver.

Significance

[edit]

The cycle's importance is based on preventing lactic acidosis during anaerobic conditions in the muscle. However, normally, before this happens, the lactic acid is moved out of the muscles and into the liver.[3]

Additionally, this cycle is important in ATP production, an energy source, during muscle exertion. The end of muscle exertion allows the Cori cycle to function more effectively. This repays the oxygen debt so both the electron transport chain and citric acid cycle can produce energy at optimum effectiveness.[3]

The Cori cycle is a much more important source of substrate for gluconeogenesis than food.[4][5] The contribution of Cori cycle lactate to overall glucose production increases with fasting duration before plateauing.[6] Specifically, after 12, 20, and 40 hours of fasting by human volunteers, gluconeogenesis accounts for 41%, 71%, and 92% of glucose production, but the contribution of Cori cycle lactate to gluconeogenesis is 18%, 35%, and 36%, respectively.[6] The remaining glucose production comes from protein breakdown,[6] muscle glycogen,[6] and glycerol from lipolysis.[7]

The drug metformin can cause lactic acidosis in patients with kidney failure because metformin inhibits the hepatic gluconeogenesis of the Cori cycle, particularly the mitochondrial respiratory chain complex 1.[8] The buildup of lactate and its substrates for lactate production, pyruvate and alanine, lead to excess lactate.[9] Normally, the excess acid that is the result of the inhibition of the mitochondrial chain complex would be cleared by the kidneys, but in patients with kidney failure, the kidneys cannot handle the excess acid. A common misconception posits that lactate is the agent responsible for the acidosis, but lactate is a conjugate base, being mostly ionised at physiologic pH, and serves as a marker of associated acid production rather than being its cause.[10][11]

See also

[edit]

References

[edit]

Further reading

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Cori cycle

View on Grokipedia
from Grokipedia
The Cori cycle, also known as the lactate cycle, is a key that facilitates the recycling of lactate produced during anaerobic glycolysis in peripheral tissues, such as and erythrocytes, back into glucose in the liver. In this process, lactate is transported via the bloodstream to the liver, where it undergoes to form glucose, which is subsequently released into circulation for uptake by glucose-dependent tissues to restore reserves. This cycle is particularly vital during conditions of high energy demand, like intense exercise or hypoxia, when oxygen supply limits aerobic metabolism, allowing the body to maintain blood glucose and prevent excessive lactate accumulation. Named after biochemists Carl Ferdinand Cori and Gerty Theresa Cori, the cycle was first described in based on their pioneering studies of in animals. The Coris' work demonstrated how in muscles breaks down to lactate under anaerobic conditions, which is then shuttled to the liver for reconversion to , highlighting the interdependent roles of muscle and liver in energy regulation. Their discovery laid foundational insights into intermediary , earning them the 1947 in Physiology or Medicine (shared with ) for related advancements in catalysis, though the cycle itself predated this recognition. The biochemical steps of the Cori cycle involve in muscles converting pyruvate to lactate, followed by hepatic uptake and conversion via gluconeogenic enzymes including , , fructose-1,6-bisphosphatase, and glucose-6-phosphatase. This pathway consumes ATP in the liver (six molecules per glucose produced) but net recycles energy by enabling sustained in oxygen-limited states. Dysregulation of the Cori cycle can contribute to metabolic disorders, such as in conditions like or mitochondrial diseases, underscoring its physiological significance.

History

Discovery

In the 1920s and 1930s, research on advanced significantly after the 1921 discovery of insulin, which highlighted disruptions in glucose handling in but left unclear the pathways for lactate utilization across organs. Early studies emphasized synthesis and breakdown isolated to muscle tissue, but Carl and shifted attention to inter-organ recycling, proposing that lactate produced in muscles during anaerobic conditions could be transported to the liver for reconversion to glucose, thereby sustaining systemic supply. This conceptual pivot addressed longstanding questions about how the body recovers from exercise-induced lactate accumulation without permanent loss of carbon units. The Coris' initial observations came in 1929, when they demonstrated through experiments on mammalian models that the liver efficiently converts to . In their seminal study, they administered d- and l- orally or intravenously to rats and measured substantial deposition in the liver, with significant increases in liver content (up to ~1% concentration) within hours, far exceeding controls. These findings, published as "Glycogen Formation in the Liver from d- and l-" in the , established the liver's gluconeogenic capacity from lactate and hinted at a cyclical process linking peripheral tissues to hepatic metabolism. To trace the muscle side, the Coris used frog preparations, incubating isolated muscles under anaerobic conditions to produce lactate via . Their work on muscle under anaerobic conditions complemented their liver findings, establishing the cyclical process. In 1929, the Coris had integrated these results into a full description of the cycle, illustrating the bidirectional flow: breakdown in muscle to lactate, hepatic resynthesis to glucose, and return to muscle for re-glycogenation. A critical contribution was their isolation of the enzyme , which they identified as the catalyst for phosphorolysis in muscle extracts. Using frog and rabbit muscle homogenates, they showed facilitates the reversible reaction of + inorganic to glucose-1- (the "Cori "), initiating lactate production during energy demand; this was crystallized from rabbit muscle by 1943, confirming its pivotal role in cycle onset. These enzymatic insights, built on balance studies tracking and levels, provided the experimental foundation for understanding the cycle's initiation and efficiency.

Recognition and Impact

In 1947, Carl Ferdinand Cori and Gerty Theresa Cori were awarded half of the in Physiology or Medicine for their discovery of the catalytic conversion of , a body of work that encompassed the elucidation of the Cori cycle as a key mechanism in ; the other half went to Bernardo Alberto Houssay for his research on the pituitary hormone's role in sugar metabolism. This recognition highlighted the cycle's significance in explaining how lactate produced during anaerobic conditions is transported to the liver for reconversion to glucose, thereby linking muscle energy demands to hepatic . Gerty Cori faced substantial institutional barriers as a female scientist, particularly at , where she joined her husband in 1931 but was appointed only as a with a salary one-tenth of his, despite their equal contributions to joint publications on metabolic pathways. University policies restricting multiple faculty positions per family further limited her advancement, confining her to non-tenure-track roles for over a decade until her promotion to in 1943 and full professor in 1947, shortly after the Nobel announcement. Their collaboration, spanning more than 50 joint papers, exemplified a rare partnership in an era when women's scientific roles were often marginalized. The Cori cycle provided a foundational framework for understanding anaerobic metabolism, demonstrating how muscles could sustain energy production without oxygen by recycling lactate, which influenced subsequent in and through the mid-20th century. This insight shifted paradigms in biochemistry by integrating peripheral tissue with central regulatory processes, paving the way for studies on hormonal influences on glucose . Their legacy endures through eponyms like the Cori ester, designating glucose-1-phosphate as the initial product of activity, which experimentally validated the cycle's enzymatic steps and advanced knowledge of . This discovery not only confirmed the pathway's efficiency but also inspired enzymatic assays that became standard in metabolic research.

Biochemical Mechanism

Anaerobic Glycolysis in Muscle

In , energy production shifts between aerobic and anaerobic pathways depending on oxygen availability. Aerobic respiration fully oxidizes glucose through , the tricarboxylic acid cycle, and in the mitochondria, generating up to 32 ATP molecules per glucose molecule when oxygen is plentiful. In contrast, anaerobic glycolysis provides a rapid but less efficient alternative, yielding only 2 ATP per glucose while avoiding dependence on oxygen, which is crucial during short bursts of high-energy demand. Glucose uptake into cells initiates this process, primarily mediated by glucose transporter type 4 (). These transporters are recruited to the in response to insulin signaling or muscle contractions, enabling efficient glucose entry from the bloodstream to support glycolytic flux. The glycolytic pathway consists of 10 enzymatic steps that convert glucose to two molecules of pyruvate in the . It begins with the ATP-dependent phosphorylation of glucose to glucose-6-phosphate by , followed by isomerization to fructose-6-phosphate. Phosphofructokinase-1 then adds another phosphate group using ATP to form fructose-1,6-bisphosphate, which splits into and glyceraldehyde-3-phosphate. The former is isomerized to the latter, yielding two glyceraldehyde-3-phosphate molecules. Each undergoes oxidation to 1,3-bisphosphoglycerate, reducing NAD⁺ to NADH and incorporating inorganic phosphate. This is followed by transferring the high-energy phosphate to ADP, producing ATP and 3-phosphoglycerate. Subsequent rearrangements yield 2-phosphoglycerate, which dehydrates to phosphoenolpyruvate via . Finally, catalyzes the transfer of the phosphate to ADP, forming pyruvate and another ATP. The net result is 2 ATP and 2 NADH produced per glucose molecule, with the initial two ATP investments offset by four generated in the later steps. Under anaerobic conditions, pyruvate cannot enter the mitochondria for further oxidation due to limited oxygen. Instead, it is reduced to lactate by (LDH), a reversible abundant in . This reaction consumes the NADH produced during : pyruvate + NADH + H⁺ → lactate + NAD⁺. The regenerated NAD⁺ is essential for sustaining the glyceraldehyde-3-phosphate dehydrogenase step, allowing to proceed at high rates without aerobic respiration. The overall simplified equation for anaerobic glycolysis in muscle is: Glucose+2ADP+2Pi→2Lactate+2ATP+2H+\text{Glucose} + 2\text{ADP} + 2\text{P}_\text{i} \rightarrow 2\text{Lactate} + 2\text{ATP} + 2\text{H}^+ This pathway is activated during intense exercise, when ATP demand in contracting muscle fibers outstrips oxygen delivery via the bloodstream, creating a hypoxic environment. As a result, lactate accumulates rapidly in the muscle, serving as both an end product and a signal of metabolic stress before being exported for further processing elsewhere.

Lactate Transport to Liver

Following anaerobic glycolysis in , lactate is released into the bloodstream primarily through the action of monocarboxylate transporter 4 (MCT4), which facilitates efflux driven by intracellular concentration gradients and proton-coupled transport. This process helps maintain by exporting lactate along with hydrogen ions during periods of high glycolytic flux. MCT1, expressed at lower levels in glycolytic fibers, primarily supports lactate influx in oxidative muscle types but contributes minimally to net efflux under anaerobic conditions. In the bloodstream, lactate circulates as a soluble anion in plasma, where it is distributed systemically without requiring active input for . At rest, plasma lactate concentrations typically range from 0.5 to 2 mM, reflecting basal metabolic turnover, but can rise to 15-25 mM during intense exercise due to accelerated production exceeding local clearance. This elevation creates a that directs lactate toward organs with high oxidative capacity, such as the liver. Upon reaching the liver, lactate is taken up by hepatocytes via MCT1 located on the sinusoidal membranes, enabling efficient influx for metabolic processing. Inside the cells, lactate is rapidly converted to pyruvate by , serving as a substrate for further hepatic . Although the transport mechanism itself is passive and facilitated diffusion-based, it integrates muscle-derived anaerobic energy output with the liver's aerobic capacity, allowing recycling without direct energy expenditure at the transport step. During heavy exercise, the liver clears the majority of circulating lactate—up to 70-80% in recovery phases—via this inter-organ pathway, preventing systemic accumulation and supporting sustained glucose availability. This clearance underscores the Cori cycle's role in coordinating fuel distribution across tissues.

Gluconeogenesis in Liver

In the liver, the gluconeogenic phase of the Cori cycle commences with the oxidation of lactate to pyruvate, catalyzed by the cytosolic enzyme (LDH), which utilizes NAD⁺ as a cofactor. This step regenerates pyruvate, the entry point for , and produces NADH that supports subsequent reductive reactions in the pathway. bypasses the three irreversible steps of —catalyzed by , phosphofructokinase-1, and /—through specialized enzymes to ensure efficient glucose synthesis from non-carbohydrate precursors like lactate. The initial committed step occurs in the mitochondria, where , a biotin-dependent , carboxylates pyruvate to form oxaloacetate, consuming ATP and : \cepyruvate+HCO3−+ATP−>oxaloacetate+ADP+Pi+H+\ce{pyruvate + HCO3- + ATP -> oxaloacetate + ADP + Pi + H+} Oxaloacetate is shuttled to the cytosol via conversion to malate (by ) and reoxidation, where (PEPCK) decarboxylates and phosphorylates it to phosphoenolpyruvate (PEP), utilizing GTP: \ceoxaloacetate+GTP−>PEP+CO2+GDP\ce{oxaloacetate + GTP -> PEP + CO2 + GDP} From PEP, the pathway reverses the remaining glycolytic steps up to fructose-1,6-bisphosphate via reversible enzymes such as , , and aldolase. Fructose-1,6-bisphosphatase then hydrolyzes fructose-1,6-bisphosphate to fructose-6-phosphate, bypassing phosphofructokinase-1. to glucose-6-phosphate follows, and glucose-6-phosphatase in the dephosphorylates it to yield free glucose, completing the synthesis. The net reaction for converting two lactate molecules to one glucose molecule in hepatic gluconeogenesis is: \ce2lactate+4ATP+2GTP+4H2O−>glucose+4ADP+2GDP+6Pi\ce{2 lactate + 4 ATP + 2 GTP + 4 H2O -> glucose + 4 ADP + 2 GDP + 6 Pi} This process demands a substantial energy investment, with 6 high-energy phosphate bonds (4 ATP + 2 GTP equivalents) consumed per glucose produced—four more than the net yield from anaerobic glycolysis in muscle—underscoring the liver's role in subsidizing systemic energy needs during periods of high demand. The NADH generated from the initial LDH reaction balances the reductive step at glyceraldehyde-3-phosphate dehydrogenase in the reverse direction. The resulting glucose is exported into the bloodstream primarily through the facilitative transporter GLUT2 on the sinusoidal membrane, enabling bidirectional flux based on concentration gradients for distribution to glucose-dependent tissues.

Physiological Role

Role in Exercise and Fatigue Prevention

During intense exercise, when oxygen demand exceeds supply, relies on anaerobic glycolysis to generate ATP rapidly. The conversion of pyruvate to lactate by regenerates NAD⁺, which is essential for sustaining and preventing the depletion of this cofactor that would otherwise halt production and accelerate fatigue. This process allows muscles to maintain high power output for extended periods, such as in sprinting or high-intensity intervals, by buffering the metabolic demands of oxygen-independent ATP synthesis. Far from being a mere waste product, lactate serves as a valuable energy substrate that is recycled via the Cori cycle, where it is transported from muscle to the liver for conversion back to glucose through . This recycled glucose can then be released into the bloodstream to fuel working muscles or other tissues. Lactate utilization, including direct oxidation and recycling via the Cori cycle, contributes approximately 30% of the total energy utilization during prolonged moderate- to high-intensity exercise, with the Cori cycle accounting for about 10% through . In endurance activities like or running, this recycling supports sustained performance by replenishing stores and maintaining blood glucose levels without solely depending on dietary intake. Endurance training enhances the efficiency of the Cori cycle through adaptations that improve lactate handling. In , regular upregulates the expression of monocarboxylate transporters (MCT1 and MCT4), facilitating faster lactate efflux and influx, which optimizes its role as a shuttle . Concurrently, hepatic adaptations increase gluconeogenic capacity from lactate by up to threefold during moderate exercise, allowing the liver to clear and repurpose larger volumes of lactate, thereby delaying the onset of in trained athletes. Despite these benefits, elevated lactate levels during intense efforts can coincide with hydrogen ion accumulation, lowering intramuscular and contributing to the sensation of muscle burn and reduced contractility. The Cori cycle mitigates this by promoting systemic lactate clearance, which indirectly aids in buffering and restoring balance more rapidly than accumulation alone would permit.

Contribution to Systemic Glucose

The Cori cycle integrates with the fed-fasting cycle by enabling the liver to utilize lactate, primarily produced by anaerobic glycolysis in peripheral tissues such as red blood cells and , as a substrate for during periods, thereby sustaining euglycemia when dietary glucose is unavailable. In the post-absorptive state, following an overnight fast, this process contributes approximately 18% to overall glucose production through lactate recycling, helping to maintain stable blood glucose levels as hepatic stores begin to deplete. This inter-organ cooperation between muscle and liver forms a shuttle that prevents by recycling lactate-derived carbon into glucose, which is then released into the circulation for use by glucose-dependent tissues. The cycle is a major contributor to in the post-absorptive state, with lactate serving as one of the primary substrates and accounting for a substantial portion (approximately 40-50%) of gluconeogenic flux. It works in tandem with the , which shuttles from muscle to liver for , but the Cori cycle's focus on lactate provides a more immediate response to increased glycolytic flux without relying on protein breakdown. Over the longer term, the Cori cycle supports systemic by fulfilling the constant glucose demands of the and red blood cells, with the requiring approximately 120 g of glucose daily. This mechanism ensures a steady supply of glucose during prolonged or low-nutrient conditions, preserving muscle integrity. Evolutionarily, the Cori cycle represents an adaptive strategy for survival in oxygen-limited environments, such as during intense , or in food-scarce conditions like , where it allows peripheral tissues to generate energy anaerobically while the liver recycles lactate to maintain circulating glucose levels.

Regulation

Enzymatic Regulation

In the muscle phase of the Cori cycle, phosphofructokinase-1 (PFK-1) acts as the primary regulatory enzyme in , committing fructose-6-phosphate to irreversible conversion to fructose-1,6-bisphosphate. PFK-1 is allosterically activated by AMP, which signals energy depletion and promotes glycolytic flux to generate ATP under anaerobic conditions. Conversely, it is inhibited by high ATP and citrate levels, which indicate sufficient energy and excess intermediates, thereby slowing to prevent unnecessary lactate accumulation. Lactate dehydrogenase (LDH) catalyzes the terminal step of anaerobic glycolysis in , reducing pyruvate to lactate while regenerating NAD⁺ to sustain . The predominant LDH in is LDH-5 (M4 homotetramer), composed of four muscle-specific M subunits, which kinetically favors lactate production over pyruvate oxidation due to its lower affinity for pyruvate and higher activity under acidic conditions. In contrast, the heart primarily expresses LDH-1 (H4 homotetramer) with H subunits that favor pyruvate reduction to support aerobic , highlighting specificity that directs toward lactate export in the Cori cycle. During prolonged anaerobic activity, lactate accumulation lowers intracellular pH, which inhibits LDH activity through reduced enzyme kinetics, establishing a feedback loop that limits further lactate production and protects against excessive acidosis. Substrate availability, such as pyruvate levels, further modulates LDH flux, ensuring coordinated glycolytic output. In the liver phase, pyruvate carboxylase initiates gluconeogenesis by carboxylating pyruvate to oxaloacetate in the mitochondria, a step allosterically activated by acetyl-CoA from fatty acid oxidation, which signals nutrient abundance and diverts pyruvate away from oxidation toward glucose synthesis. Fructose-1,6-bisphosphatase then hydrolyzes fructose-1,6-bisphosphate to fructose-6-phosphate, countering the glycolytic PFK-1 reaction; it is potently inhibited by fructose-2,6-bisphosphate, an allosteric effector that prevents simultaneous glycolysis and gluconeogenesis to avoid futile ATP hydrolysis. Glucose-6-phosphatase serves as the final gatekeeper, dephosphorylating glucose-6-phosphate to release free glucose into circulation, with its activity primarily regulated by substrate concentration to match hepatic glucose output to systemic demand. High ATP levels in the liver energetically tune the cycle toward by inhibiting key glycolytic enzymes like PFK-1 while supporting the ATP-dependent steps of , such as those catalyzed by . Overall flux through the Cori cycle is also governed by substrate availability, with lactate serving as the primary input to hepatic . Hormonal signals can modulate these intrinsic enzymatic mechanisms to fine-tune cycle activity.

Hormonal and Metabolic Control

The Cori cycle is modulated by key hormones that integrate systemic metabolic demands, particularly through their effects on hepatic from lactate. and epinephrine both stimulate this process by activating the cAMP/ (PKA) signaling pathway in hepatocytes, which leads to increased expression and activity of gluconeogenic enzymes such as and (PEPCK). This enhances the liver's capacity to convert lactate derived from muscle back into glucose, thereby supporting the cycle during or stress states when blood glucose levels decline. In contrast, insulin acts to suppress the Cori cycle activity, predominantly in the fed state, by promoting and while inhibiting in the liver. It achieves this through of key regulatory enzymes and enhanced glucose uptake via translocation of transporters, thereby reducing the availability of substrates like lactate for gluconeogenic recycling. , as a hormone elevated during , further upregulates gluconeogenic enzymes including PEPCK, promoting the utilization of lactate and other precursors to elevate blood glucose levels and sustain the cycle under prolonged catabolic conditions. Metabolic states also exert control over the Cori cycle through sensors responsive to hypoxia and availability. In , hypoxia-inducible factor-1 (HIF-1) is activated under low oxygen conditions, boosting the expression of glycolytic enzymes and thereby increasing lactate production as a substrate for hepatic recycling. In the liver, conditions of cellular depletion (high AMP/ATP ratio) activate (AMPK), which inhibits by suppressing expression of key enzymes such as PEPCK and glucose-6-phosphatase, thereby limiting conversion of lactate to glucose and modulating Cori cycle flux to conserve . During exercise, these regulatory mechanisms converge, with catecholamines like epinephrine accelerating lactate generation in muscle through enhanced while simultaneously promoting its rapid hepatic uptake and conversion to glucose, ensuring efficient energy redistribution across tissues. This hormonal and metabolic integration maintains systemic glucose by dynamically balancing production and utilization of lactate.

Clinical Implications

Association with Lactic Acidosis

Lactic acidosis arises when the Cori cycle, responsible for converting lactate produced in peripheral tissues back to glucose in the liver, becomes disrupted, leading to accumulation of lactate and subsequent . In this condition, excessive lactate production or impaired hepatic clearance overwhelms the cycle's capacity, resulting in systemic . Disruptions can occur through increased lactate generation or failure in , exacerbating the imbalance between lactate supply and . Type A lactic acidosis is associated with tissue hypoxia, such as in , , or severe exercise, where anaerobic glycolysis produces lactate at rates exceeding the liver's clearance via the Cori cycle. This overload occurs because hypoxic conditions shift toward lactate formation, saturating hepatic gluconeogenic enzymes and transporters, thereby preventing efficient recycling. Examples include hypoperfusion states where lactate levels rise due to inadequate oxygen delivery, directly challenging the cycle's hepatic arm. In contrast, type B lactic acidosis develops without hypoxia and stems from impaired within the Cori cycle, often due to underlying liver dysfunction or pharmacological interference. Conditions like reduce the liver's ability to process lactate into glucose, leading to persistent elevation. drugs such as metformin exemplify this by inhibiting mitochondrial respiration and , thereby blocking lactate conversion and promoting accumulation independent of oxygen status. Diagnosis of lactic acidosis linked to Cori cycle dysfunction typically involves measuring blood lactate levels exceeding 4-5 mmol/L alongside a below 7.35 and reduced , confirming . The cycle's incomplete recycling exacerbates this by failing to clear lactate, allowing it to protonate and lower further; gas analysis and serum lactate assays are standard for verification. Symptoms include nonspecific signs like , , and altered mental status, reflecting the acidotic state. Treatment strategies address Cori cycle inefficiencies by targeting lactate clearance or correction. therapy neutralizes excess protons, temporarily alleviating drop while supporting residual cycle function, though it does not directly enhance . Dichloroacetate activates , diverting lactate-derived pyruvate away from the Cori cycle toward oxidation in mitochondria, partially bypassing impaired recycling and reducing lactate levels. These interventions aim to restore metabolic balance, with efficacy depending on the underlying cause. Lactic acidosis associated with Cori cycle disruption is prevalent in intensive care unit settings, affecting up to 20-30% of critically ill patients with or shock. Severe cases, marked by cycle inefficiency and lactate persistence, carry a approaching 50-60%, underscoring the prognostic significance of timely intervention.

Relevance to Metabolic Disorders

In (GSD I), also known as von Gierke disease, deficiency of glucose-6-phosphatase impairs the final step of , preventing the conversion of lactate-derived glucose-6-phosphate to free glucose and thereby blocking completion of the Cori cycle. This leads to hepatic accumulation, severe , and elevated lactate levels due to shunting of glycolytic intermediates toward lactate production rather than glucose release. Diagnosis often involves measuring hyperlactatemia alongside , while therapeutic strategies like frequent feeding aim to bypass the cycle's disruption and maintain euglycemia. Mitochondrial disorders, characterized by defects in the , increase reliance on anaerobic glycolysis for ATP production, resulting in excessive lactate generation that overloads the Cori cycle's capacity for hepatic clearance. This chronic lactate elevation contributes to persistent hyperlactatemia and , distinguishing these conditions from acute states and serving as a key for disease severity. Therapeutic interventions, such as supplementation, may partially mitigate lactate buildup by enhancing residual mitochondrial function and supporting cycle efficiency. In diabetes, particularly type 1 with insulin deficiency, reduced suppression of leads to heightened Cori cycle flux, where increased lactate from peripheral tissues is preferentially converted to glucose in the liver, exacerbating . This enhanced cycle activity overlaps with by promoting futile glucose cycling, though targeting gluconeogenic enzymes like offers potential for therapeutic inhibition to improve glycemic control. In associated with , impaired lactate clearance further amplifies cycle dysregulation, contributing to . Cancer cells exploit the Warburg effect—aerobic producing high lactate levels—to fuel rapid proliferation, potentially hijacking the Cori cycle by exporting lactate to the liver for glucose regeneration that supports tumor energy demands. This metabolic reprogramming not only sustains tumor growth but also induces systemic in host tissues, highlighting the cycle's role in cancer . Emerging therapies targeting lactate transporters (e.g., MCT1) aim to disrupt this lactate-fueled cycle and starve tumors of recycled glucose. Post-2000 research has elucidated the Cori cycle's involvement in and , where chronic exercise training enhances hepatic lactate clearance and reduces fasting lactate levels, improving overall metabolic flexibility. Studies demonstrate that interventions increase monocarboxylate transporter expression, facilitating better cycle efficiency and aiding in obese diabetic patients. These findings underscore exercise as a non-pharmacological to restore cycle function and mitigate in .

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK541119/
  2. https://www.acs.org/education/whatischemistry/landmarks/carbohydratemetabolism.html
  3. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cori-cycle
  4. https://www.ncbi.nlm.nih.gov/books/NBK557536/
  5. https://www.acs.org/content/dam/acsorg/education/whatischemistry/landmarks/carbohydratemetabolism/carl-and-gerty-cori-and-carbohydrate-metabolism-commemorative-booklet.pdf
  6. https://www.sciencehistory.org/education/scientific-biographies/carl-ferdinand-cori-and-gerty-theresa-cori/
  7. https://www.nobelprize.org/uploads/2018/06/cori-lecture.pdf
  8. https://www.jbc.org/article/S0021-9258(18)83822-4/fulltext
  9. https://www.nobelprize.org/prizes/medicine/1947/summary/
  10. https://www.nobelprize.org/stories/women-who-changed-science/gerty-cori/
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC11472862/
  12. https://beckerexhibits.wustl.edu/legacy-exhibits/mig/bios/corig.html
  13. https://www.ncbi.nlm.nih.gov/books/NBK546695/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC7672939/
  15. https://www.khanacademy.org/science/ap-biology/cellular-energetics/cellular-respiration-ap/a/fermentation-and-anaerobic-respiration
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC11274880/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC2269375/
  18. https://journals.biologists.com/jeb/article/208/24/4561/15901/Lactate-a-signal-coordinating-cell-and-systemic
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC2769631/
  20. https://www.mdpi.com/1422-0067/21/5/1606
  21. https://www.nature.com/articles/s41392-022-01151-3
  22. https://emedicine.medscape.com/article/167027-overview
  23. https://link.springer.com/article/10.1007/s00125-014-3451-1
  24. https://bio.libretexts.org/Bookshelves/Biochemistry/Fundamentals_of_Biochemistry_(Jakubowski_and_Flatt)/02:Unit_II-_Bioenergetics_and_Metabolism/13:Glycolysis_Gluconeogenesis_and_the_Pentose_Phosphate_Pathway/13.03:Gluconeogenesis
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC10812926/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC8124511/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC9434547/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC2976763/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC8632521/
  30. https://journals.physiology.org/doi/full/10.1152/ajpendo.1998.275.3.E537
  31. https://www.nature.com/scitable/topicpage/dynamic-adaptation-of-nutrient-utilization-in-humans-14232807/
  32. https://www.sciencedirect.com/science/article/pii/S0261561421000868
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC11345425/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC6541852/
  35. https://www.ttuhsc.edu/medicine/academic-affairs/documents/sakai-files/bct/7_Glycolysis_Notes_Ganapathy.pdf
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC3156596/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC4343186/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC9694104/
  39. https://pubmed.ncbi.nlm.nih.gov/6260770/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC1222414/
  41. https://www.chem.fsu.edu/~rlight/4054s01/Lectures/Chapter23.pdf
  42. https://www.tandfonline.com/doi/full/10.1080/23311932.2016.1267691
  43. https://pubmed.ncbi.nlm.nih.gov/2985455/
  44. https://pubmed.ncbi.nlm.nih.gov/842622/
  45. https://pubmed.ncbi.nlm.nih.gov/11724664/
  46. https://portlandpress.com/clinsci/article/101/6/739/67449/Cortisol-increases-gluconeogenesis-in-humans-its
  47. https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP280572
  48. https://portlandpress.com/biochemj/article/480/1/105/232441/AMPK-inhibits-liver-gluconeogenesis-fact-or
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC3688748/
  50. https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2011.00112/full
  51. https://pubmed.ncbi.nlm.nih.gov/25465888/
  52. https://www.ncbi.nlm.nih.gov/books/NBK470202/
  53. https://litfl.com/lactate-and-lactic-acidosis/
  54. https://www.ncbi.nlm.nih.gov/books/NBK580485/
  55. https://my.clevelandclinic.org/health/diseases/25066-lactic-acidosis
  56. https://pubmed.ncbi.nlm.nih.gov/28772222/
  57. https://ccforum.biomedcentral.com/articles/10.1186/cc3987
  58. https://www.ncbi.nlm.nih.gov/books/NBK534196/
  59. https://medlineplus.gov/genetics/condition/glycogen-storage-disease-type-i/
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC6050127/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC8439166/
  62. https://journals.physiology.org/doi/full/10.1152/ajpendo.2001.280.1.E23
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC5927596/
  64. https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.652023/full
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC9627643/
Add your contribution
Related Hubs
User Avatar
No comments yet.